Jonathan Aschoff analyst

Currently out of the existing stock ratings of Jonathan Aschoff, 81 are a BUY (86.17%), 10 are a HOLD (10.64%), 3 are a SELL (3.19%).

Jonathan Aschoff

Work Performance Price Targets & Ratings Chart

Analyst Jonathan Aschoff works with a stock forecast success ratio of 32.27% fulfilled within 208.92 days on average.

Jonathan Aschoff’s has documented 160 price targets and ratings displayed on 27 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on CYCC, Cyclacel Pharmaceuticals at 03-May-2024.

Wall Street Analyst Jonathan Aschoff

Analyst best performing recommendations are on PBLA (PANBELA THERAPEUTICS).
The best stock recommendation documented was for PBLA (PANBELA THERAPEUTICS) at 12/18/2023. The price target of $25 was fulfilled within 1 day with a profit of $4.8 (23.76%) receiving and performance score of 237.62.

Average potential price target upside

ALXN Alexion Pharmaceuticals APDN Applied DNA Sciences APVO Aptevo Therapeutics INCY yte INO Inovio Pharmaceuticals MBRX Moleculin Biotech SEEL Seelos Therapeutics TFFP Tff Pharmaceuticals VVUS VIVUS CLDX Celldex Therapeutics PGNX Progenics Pharmaceuticals REGN Regeneron Pharmaceuticals AZRX AzurRx BioPharma CMRX Chimerix BPTH Bio Path Holdings FWBI First Wave BioPharma NOVN Novan REVB Revelation Biosciences KMPH KemPharm AKBA Akebia Ther BFRI Biofrontera CLRB Cellectar Biosciences HRTX Heron Therapeuti ACER Acer Therapeutics TTPH Tetraphase Pharmaceuticals CYCC Cyclacel Pharmaceuticals PBLA Panbela Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

205

$22.5 (12.33%)

3 years 13 days ago

3/5 (60%)

$35.09 (20.65%)

938

Hold

173

$-9.5 (-5.21%)

156

3 years 15 days ago

14/24 (58.33%)

$2.73 (1.60%)

682

Hold

190

$7.5 (4.11%)

194

3 years 3 months 14 days ago

9/11 (81.82%)

$34.41 (22.12%)

350

Hold

166

$-16.5 (-9.04%)

175

3 years 3 months 14 days ago

23/23 (100%)

$10.41 (6.69%)

828

Buy

155

3 years 4 months 11 days ago

7/7 (100%)

$36.79 (31.12%)

395

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Jonathan Aschoff is most bullish on?

Potential upside of $34.92 has been obtained for MBRX (MOLECULIN BIOTECH)

Which stock is Jonathan Aschoff is most reserved on?

Potential downside of -$0 has been obtained for PBLA (PANBELA THERAPEUTICS)

What Year was the first public recommendation made by Jonathan Aschoff?

On 2008

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?